Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Immix Biopharma, Inc. has filed 235 SEC EDGAR filings since 20 Jul 2021

SEC filing history

Showing 76-100 of 235 matching filings.

Per page
25
Current page
4
4

4 filing

Filing date
26 Aug 2024
Reporting date
21 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Aug 2024
Reporting date
16 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41159

10-Q filing

Filing date
12 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
4

4 filing

Filing date
31 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-280929

S-8 filing

Filing date
22 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
11 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2024
Reporting date
04 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jun 2024
Reporting date
04 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-41159

DEFA14A filing

Filing date
21 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-513789

D filing

Filing date
20 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 May 2024
Reporting date
20 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .